One important metric to look for in a stock is an 80 or higher Relative Strength Rating. Sabra Healthcare REIT stock now clears that threshold, with a jump from 78 to 82 Monday.
IBD's unique RS Rating measures market leadership by showing how a stock's price movement over the last 52 weeks compares to that of the other stocks in our database.
Over 100 years of market history reveals that the market's biggest winners typically have an 80 or higher RS Rating as they begin their biggest price moves.
Looking For The Best Stocks To Buy And Watch? Start Here
Is Sabra Healthcare REIT Stock A Buy?
Sabra Healthcare REIT stock is trying to complete a consolidation with a 20.03 buy point. See if the stock can clear the breakout price in heavy trading. This is not the time to buy stocks during a market correction, but build a watchlist of possible emerging leaders once the market trend turns around.
Earnings growth slowed in the most recent quarter from 9% to 6%. But revenue moved higher, from 10% to 12%. The company is expected to report its latest performance numbers on or around Apr. 30.
Sabra Healthcare REIT stock holds the No. 10 rank among its peers in the Finance-Property REITs industry group. CareTrust REIT, Essex Property Trust and Curbline Properties are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
